Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.83 USD | +2.28% |
|
+8.16% | +60.16% |
06-22 | MannKind Corporation Announces Positive 17-Week Results from the INHALE-3 Study | CI |
05-29 | MannKind Agrees to Cross License Deal With Pulmatrix | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+60.16% | 1.59B | |
+20.63% | 127B | |
+24.98% | 27.67B | |
-20.17% | 20.33B | |
-16.80% | 16.79B | |
-18.07% | 15.63B | |
-47.70% | 14.65B | |
+11.92% | 14.84B | |
+58.32% | 14.43B | |
+149.98% | 12.49B |
- Stock Market
- Equities
- MNKD Stock
- News MannKind Corporation
- Transcript : MannKind Corporation Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-12-2023 11